| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/27/2003 | CN1438030A Method for preparing tumor specific transfer factors |
| 08/27/2003 | CN1438029A Composite medicine for emergency treatment of acute poisouing by Tetramine |
| 08/27/2003 | CN1119421C Recombinant fusion proteins to growth hormone and serum albumin |
| 08/27/2003 | CN1119416C Human interleukin 2 derivatives and human heart sodium medium fusion gene, its protein products and uts thereof |
| 08/27/2003 | CN1119351C Cyclic adhesion inhibitors |
| 08/27/2003 | CN1119350C Somatotropin releasing peptide |
| 08/27/2003 | CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 08/27/2003 | CN1119171C Pharmaceutical using of bradykinin-antagonist in preparation of drug for treating uiral illness |
| 08/27/2003 | CN1119170C Use of micrococcin antibiotics for the preparation of pharmaceuticals for treating or preventing mastitis |
| 08/27/2003 | CN1119169C Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof |
| 08/27/2003 | CN1119146C Compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 08/27/2003 | CN1119080C Implantable agarose-collagen beads containing cells which produce a diffusible bilogical product, and uses thereof |
| 08/26/2003 | USRE38240 DNA encoding human endothelial cell growth factors and plasmids comprising said DNA |
| 08/26/2003 | US6610906 Nucleotide sequences for gene regulation and methods of use thereof |
| 08/26/2003 | US6610839 Promoter for telomerase reverse transcriptase |
| 08/26/2003 | US6610833 Hybridoma cell line; immunoglobulins; can use in treating human immunodeficiency virus infections |
| 08/26/2003 | US6610832 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 08/26/2003 | US6610830 Microbial production of mature human leukocyte interferons |
| 08/26/2003 | US6610829 Human extracellular matrix-1 |
| 08/26/2003 | US6610826 Cyclopeptide derivatives with integrin inhibitor properties |
| 08/26/2003 | US6610825 Method for alleviating pain or providing an analgesic effect in a patient |
| 08/26/2003 | US6610824 Amylin agonist peptides and uses therefor |
| 08/26/2003 | US6610821 Cyclic peptide of given amino acid sequence; can use to improve drug delivery process, inhibit angiogenesis, increase vasopermeability; treatment of autoimmune and inflammatory diseases |
| 08/26/2003 | US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 08/26/2003 | US6610748 substance having human leukocyte elastase inhibitory activity as an active ingredient. |
| 08/26/2003 | US6610746 Treating non-insulin dependent diabetes mellitus, insulin resistance, Syndrome X, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic cardiomyopathy, polycystic ovary syndrome, cataracts and hyperglycemia; kits |
| 08/26/2003 | US6610735 Coadministration of a an oral bioavailability-enhancing agent (e.g., a cyclosporin F or ketoconazole) with a drug that exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide) |
| 08/26/2003 | US6610730 Viricides; protease inbhibitor |
| 08/26/2003 | US6610722 Inhibitors of prenyl-protein transferase |
| 08/26/2003 | US6610706 Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 08/26/2003 | US6610699 Use of L-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity |
| 08/26/2003 | US6610689 Viricides |
| 08/26/2003 | US6610683 Treatment of infectious disease using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors |
| 08/26/2003 | US6610681 Neurotherapeutic clavulanate composition and method |
| 08/26/2003 | US6610664 Cationic lipids |
| 08/26/2003 | US6610663 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers |
| 08/26/2003 | US6610661 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 08/26/2003 | US6610659 Use of heat shock protein 70 preparations in vaccination against cancer and infectious disease |
| 08/26/2003 | US6610658 Modulators of μ-amyloid peptide aggregation |
| 08/26/2003 | US6610657 Reducing semen migration using polypeptides which inhibit binding of protein kinases; contraceptives; antifertility agents |
| 08/26/2003 | US6610656 Activating osteogenesis using hedgehog genes or proteins coded by hybridized nucleic acids |
| 08/26/2003 | US6610655 Pentapeptide with specific conformation, its production and use |
| 08/26/2003 | US6610654 Antiproliferative agents selected from hemoglobins and macrophage inflammatory proteins, transforming growth factors, tumor necrosis factors, interferons or peptides; controlling progenitor cells after exposure to radiation or drugs |
| 08/26/2003 | US6610653 Powder dispensers containing insulin and absorption intensifiers such as sodium caprate; antidiabetic agents |
| 08/26/2003 | US6610652 Administration of at least one agent at a level which enhances NO and which does not appreciably alter normal systemic vascular tone |
| 08/26/2003 | US6610651 Molecules that home to various selected organs or tissues |
| 08/26/2003 | US6610650 Modulation of cellular transcription factor activity |
| 08/26/2003 | US6610649 To stimulate Na+K+ATPase activity which has been shown to be reduced in patients with insulin-dependent diabetes mellitus to treat or prevent diabetic neuropathy, nephropathy and retinopathy |
| 08/26/2003 | US6610542 Human immunodeficiency virus; incubating umbilical cord blood cells in a growth medium containing mezerin and concanavalin A; culturing while maintaining reduced levels of the virus; gene expression inhibition |
| 08/26/2003 | US6610541 Recombinant, active caspases and uses thereof |
| 08/26/2003 | US6610540 Low oxygen culturing of central nervous system progenitor cells |
| 08/26/2003 | US6610539 Modulate the expression of the ribonucleotide reductase or the secA genes in microorganisms. This invention is also related to methods of using such oligonucleotides in inhibiting the growth of microorganisms. These antisense oligonucleotides are |
| 08/26/2003 | US6610536 Nucleic acids and polypeptides |
| 08/26/2003 | US6610534 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
| 08/26/2003 | US6610532 Treating or preventing heart defects in mammals; obtain human, administer modulator, monitor humans for adjustment in heart activity |
| 08/26/2003 | US6610526 Human E1-like protein |
| 08/26/2003 | US6610523 Human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating |
| 08/26/2003 | US6610520 Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby |
| 08/26/2003 | US6610515 Medicine which promotes the production of neutrophiles in case the number of the neutrophiles decreases upon treating the tumor of a cat, and does not have side-effects, wherein said medicine is prepared by incorporating, as an active |
| 08/26/2003 | US6610513 Receptor proteins |
| 08/26/2003 | US6610512 Zinc finger binding domains for GNN |
| 08/26/2003 | US6610510 Human Cerberus proteins and related nucleic acids are provided. Included are proteins comprising a human cerberus domain having specific activity, particularly the ability to antagonize a bone morphogenic protein. The proteins may be |
| 08/26/2003 | US6610505 Oncoprotein protein kinase |
| 08/26/2003 | US6610500 Agonistic anti-human TrkA mAb 5C3 which recognizes the NGF docking site. Such antibodies may be used for the treatment, diagnosis or prevention of neurological diseases, neuromas and neoplastic tumors which express TrkA receptors. |
| 08/26/2003 | US6610497 Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor |
| 08/26/2003 | US6610493 Screening compounds for the ability to alter the production of amyloid-β peptide |
| 08/26/2003 | US6610480 Identification of genes which are differentially expressed in hypertrophic cardiac tissue as compared to normal cardiac tissue. Accordingly, the present invention provides nucleotide sequences of genes and promotion or inhibition of the function |
| 08/26/2003 | US6610478 Phenotypic conversion of cells mediated by external guide sequences |
| 08/26/2003 | US6610477 Human DNA mismatch repair proteins |
| 08/26/2003 | US6610476 Nucleotide sequence of HTLV-III DNA; identification, isolation and expression of HTLV-III sequences which encode immunoreactive polypeptides by recombinant,DNA methods and production of viral RNA are disclosed. Such polypeptides can |
| 08/26/2003 | US6610473 Peptides for inhibiting HPV E6-proteins |
| 08/26/2003 | US6610334 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins |
| 08/26/2003 | US6610329 Compositions for the delivery of antigens |
| 08/26/2003 | US6610322 Liposome suspension forms spontaneously upon adding a diacylglycerol-PEG lipid to an aqueous solution when the lipid has appropriate packing parameters and the adding occurs above the melting temperature of the lipid. Combinations of lipids |
| 08/26/2003 | US6610307 Immunity against pasteurella haemolytica leukotoxin |
| 08/26/2003 | US6610304 Peptides having activity against HIV into liposomes of sufficient size for white blood cell internalization (e.g. greater than 150 nm and preferably approximately 250-400 nm.) has been shown to increase the activity of those MBPCs |
| 08/26/2003 | US6610303 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them |
| 08/26/2003 | US6610302 Peptides for the treatment and amelioration of tumor-producing diseases, and methods for their utilization. |
| 08/26/2003 | US6610299 Glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates for treating cancers. |
| 08/26/2003 | US6610297 Compositions for treating allergies that include either BSW17 mimotope peptides or antibodies raised against BSW17 mimotope peptides. Also disclosed are methods for the treatment of allergies which involve administration of BSW17 mimeotope |
| 08/26/2003 | US6610296 Therapy for central nervous system disorders |
| 08/26/2003 | US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds |
| 08/26/2003 | US6610293 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 08/26/2003 | US6610292 Therapy for vision defects |
| 08/26/2003 | US6610290 Transferring preferential nucleotide sequences to cells; obtain cells, incubate with expression vector, transform cells, recover transformed cells |
| 08/26/2003 | US6610286 Administering interleukin antagonist |
| 08/26/2003 | US6610285 A full-length cDNA corresponding to an EST (AA418955), which does not show any homology to other proteins in the database but has a weak homology to G-CSF, has been successfully isolated by synthesizing primers based on the EST sequence, |
| 08/26/2003 | US6610043 Tissue volume reduction |
| 08/26/2003 | CA2309033C Lacrimal gland specific emulsions for topical application to ocular tissue |
| 08/26/2003 | CA2277896C Preparation of collagen |
| 08/25/2003 | CA2405347A1 Medicament comprising nk4 gene or recombinant nk4 protein |
| 08/22/2003 | CA2372708A1 Combination treatment with t-pa variant and low molecular weight heparin |
| 08/21/2003 | WO2003069346A2 Diagnostic method for stroke |
| 08/21/2003 | WO2003069310A2 Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia |
| 08/21/2003 | WO2003069307A2 Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer |
| 08/21/2003 | WO2003068977A2 Fusion constructs containing active sections of tnf ligands |
| 08/21/2003 | WO2003068975A1 ss-LACTAMASE/ANMINOGLYCOSIDES MODIFYING ENZYME GENES, THEIR FUSION GENE AND THE EXPRESSION PRODUCTS, THE COMPOSITION THEREOF, AND THEIR USES IN MEDICINE AND ENVIRONMENTAL PROTECTION |
| 08/21/2003 | WO2003068973A1 Dna sequence useful in diagnosing hepatitis and polypeptide encoded thereby |
| 08/21/2003 | WO2003068970A1 Sodium-independent transporter carrying acidic amino acid and its gene |
| 08/21/2003 | WO2003068968A2 Mutated gene coding for a lat protein and the biological applications thereof |